# CRA International, Inc.: financial statements, quarterly

CRAI · Nasdaq · CIK 1053706 · [Other](/sectors/other.md) · fiscal year ends Jan 2

Pages: [Overview](/companies/crai.md) · [Financials](/companies/crai/financials.md) · [Filings](/companies/crai/filings.md) · [Insiders](/companies/crai/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/crai/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-30) | Q1 FY2024 (2024-03-30) | Q2 FY2024 (2024-06-29) | Q3 FY2024 (2024-09-28) | Q4 FY2024 (2024-12-28) | Q1 FY2025 (2025-03-29) | Q2 FY2025 (2025-06-28) | Q3 FY2025 (2025-09-27) | Q4 FY2025 (2026-01-03) | Q1 FY2026 (2026-04-04) | Q2 FY2026 (2026-07-04) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [148](/filings/0001053706-24-000026.md) | [162 d](/filings/0001053706-26-000006.md) | [172](/filings/0001053706-25-000014.md) | [171](/filings/0001053706-25-000020.md) | [168](/filings/0001053706-25-000029.md) | [176 d](/filings/0001053706-26-000006.md) | [182](/filings/0001053706-26-000014.md) | [187](/filings/0001053706-26-000021.md) | [186](/filings/0001053706-25-000029.md) | [197 d](/filings/0001053706-26-000006.md) | [201](/filings/0001053706-26-000014.md) | [211](/filings/0001053706-26-000021.md) |
| Cost of revenue | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Gross profit | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Selling, general and administrative | $m | [27.9](/filings/0001053706-24-000026.md) | [29.0 d](/filings/0001053706-26-000006.md) | [30.5](/filings/0001053706-25-000014.md) | [32.0](/filings/0001053706-25-000020.md) | [31.3](/filings/0001053706-25-000029.md) | [31.3 d](/filings/0001053706-26-000006.md) | [32.5](/filings/0001053706-26-000014.md) | [35.1](/filings/0001053706-26-000021.md) | [33.7](/filings/0001053706-25-000029.md) | [33.7 d](/filings/0001053706-26-000006.md) | [34.5](/filings/0001053706-26-000014.md) | [35.3](/filings/0001053706-26-000021.md) |
| Operating income | $m | [10.8](/filings/0001053706-24-000026.md) | [17.1 d](/filings/0001053706-26-000006.md) | [19.6](/filings/0001053706-25-000014.md) | [11.3](/filings/0001053706-25-000020.md) | [18.4](/filings/0001053706-25-000029.md) | [21.5 d](/filings/0001053706-26-000006.md) | [25.5](/filings/0001053706-26-000014.md) | [19.7](/filings/0001053706-26-000021.md) | [17.2](/filings/0001053706-25-000029.md) | [20.6 d](/filings/0001053706-26-000006.md) | [18.0](/filings/0001053706-26-000014.md) | [23.5](/filings/0001053706-26-000021.md) |
| Interest expense | $m | [1.0](/filings/0001053706-24-000026.md) | [0.6 d](/filings/0001053706-24-000006.md) | [0.5](/filings/0001053706-25-000014.md) | [1.5](/filings/0001053706-25-000020.md) | [1.5](/filings/0001053706-25-000029.md) | [1.0 d](/filings/0001053706-26-000006.md) | [0.4](/filings/0001053706-26-000014.md) | [1.8](/filings/0001053706-26-000021.md) | [1.8](/filings/0001053706-25-000029.md) | [1.4 d](/filings/0001053706-26-000006.md) | [1.0](/filings/0001053706-26-000014.md) | [3.0](/filings/0001053706-26-000021.md) |
| Income tax | $m | [1.9](/filings/0001053706-24-000026.md) | [4.1 d](/filings/0001053706-26-000006.md) | [5.3](/filings/0001053706-25-000014.md) | [3.1](/filings/0001053706-25-000020.md) | [4.6](/filings/0001053706-25-000029.md) | [6.6 d](/filings/0001053706-26-000006.md) | [6.6](/filings/0001053706-26-000014.md) | [5.0](/filings/0001053706-26-000021.md) | [4.8](/filings/0001053706-25-000029.md) | [5.4 d](/filings/0001053706-26-000006.md) | [6.3](/filings/0001053706-26-000014.md) | [6.6](/filings/0001053706-26-000021.md) |
| Net income | $m | [8.6](/filings/0001053706-24-000026.md) | [11.5 d](/filings/0001053706-26-000006.md) | [13.7](/filings/0001053706-25-000029.md) | [6.5](/filings/0001053706-25-000029.md) | [11.4](/filings/0001053706-25-000029.md) | [15.0 d](/filings/0001053706-26-000006.md) | [18.0](/filings/0001053706-26-000021.md) | [12.1](/filings/0001053706-26-000021.md) | [11.5](/filings/0001053706-25-000029.md) | [13.2 d](/filings/0001053706-26-000006.md) | [11.1](/filings/0001053706-26-000021.md) | [13.5](/filings/0001053706-26-000021.md) |
| Diluted EPS | $ per share | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Basic EPS | $ per share | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |

- Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
- Cost of revenue: not reported
- Gross profit: not reported
- Selling, general and administrative: us-gaap:SellingGeneralAndAdministrativeExpense
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: us-gaap:InterestExpense, us-gaap:InterestExpenseNonoperating
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: not reported
- Basic EPS: not reported

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-30) | Q1 FY2024 (2024-03-30) | Q2 FY2024 (2024-06-29) | Q3 FY2024 (2024-09-28) | FY2024 (2024-12-28) | Q1 FY2025 (2025-03-29) | Q2 FY2025 (2025-06-28) | Q3 FY2025 (2025-09-27) | FY2025 (2026-01-03) | Q1 FY2026 (2026-04-04) | Q2 FY2026 (2026-07-04) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [27.6](/filings/0001053706-23-000026.md) | [45.6](/filings/0001053706-25-000007.md) | [37.1](/filings/0001053706-24-000013.md) | [24.6](/filings/0001053706-24-000020.md) | [24.5](/filings/0001053706-24-000026.md) | [26.7](/filings/0001053706-26-000006.md) | [25.6](/filings/0001053706-25-000014.md) | [19.4](/filings/0001053706-25-000020.md) | [22.5](/filings/0001053706-25-000029.md) | [18.2](/filings/0001053706-26-000021.md) | [32.5](/filings/0001053706-26-000014.md) | [21.4](/filings/0001053706-26-000021.md) |
| Current assets | $m | [249](/filings/0001053706-23-000026.md) | [265](/filings/0001053706-25-000007.md) | [275](/filings/0001053706-24-000013.md) | [271](/filings/0001053706-24-000020.md) | [286](/filings/0001053706-24-000026.md) | [269](/filings/0001053706-26-000006.md) | [278](/filings/0001053706-25-000014.md) | [293](/filings/0001053706-25-000020.md) | [306](/filings/0001053706-25-000029.md) | [303](/filings/0001053706-26-000021.md) | [316](/filings/0001053706-26-000014.md) | [339](/filings/0001053706-26-000021.md) |
| Total assets | $m | [539](/filings/0001053706-23-000026.md) | [553](/filings/0001053706-25-000007.md) | [553](/filings/0001053706-24-000013.md) | [546](/filings/0001053706-24-000020.md) | [582](/filings/0001053706-24-000026.md) | [571](/filings/0001053706-26-000006.md) | [590](/filings/0001053706-25-000014.md) | [607](/filings/0001053706-25-000020.md) | [629](/filings/0001053706-25-000029.md) | [629](/filings/0001053706-26-000021.md) | [662](/filings/0001053706-26-000014.md) | [678](/filings/0001053706-26-000021.md) |
| Current liabilities | $m | [224](/filings/0001053706-23-000026.md) | [236](/filings/0001053706-25-000007.md) | [237](/filings/0001053706-24-000013.md) | [253](/filings/0001053706-24-000020.md) | [268](/filings/0001053706-24-000026.md) | [251](/filings/0001053706-26-000006.md) | [271](/filings/0001053706-25-000014.md) | [317](/filings/0001053706-25-000020.md) | [339](/filings/0001053706-25-000029.md) | [330](/filings/0001053706-26-000021.md) | [381](/filings/0001053706-26-000014.md) | [415](/filings/0001053706-26-000021.md) |
| Current portion of debt | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Short-term borrowings | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Shareholders' equity | $m | [208](/filings/0001053706-24-000026.md) | [212](/filings/0001053706-26-000006.md) | [212](/filings/0001053706-25-000029.md) | [192](/filings/0001053706-25-000029.md) | [205](/filings/0001053706-25-000029.md) | [212](/filings/0001053706-26-000021.md) | [227](/filings/0001053706-26-000021.md) | [197](/filings/0001053706-26-000021.md) | [202](/filings/0001053706-25-000029.md) | [214](/filings/0001053706-26-000021.md) | [198](/filings/0001053706-26-000021.md) | [182](/filings/0001053706-26-000021.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Current portion of debt: not reported
- Short-term borrowings: not reported
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-30) | Q1 FY2024 (2024-03-30) | Q2 FY2024 (2024-06-29) | Q3 FY2024 (2024-09-28) | Q4 FY2024 (2024-12-28) | Q1 FY2025 (2025-03-29) | Q2 FY2025 (2025-06-28) | Q3 FY2025 (2025-09-27) | Q4 FY2025 (2026-01-03) | Q1 FY2026 (2026-04-04) | Q2 FY2026 (2026-07-04) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [65.0 d](/filings/0001053706-24-000026.md) | [60.1 d](/filings/0001053706-26-000006.md) | [(63.1)](/filings/0001053706-25-000014.md) | [1.8 d](/filings/0001053706-25-000020.md) | [31.6 d](/filings/0001053706-25-000029.md) | [79.4 d](/filings/0001053706-26-000006.md) | [(80.0)](/filings/0001053706-26-000014.md) | [5.9 d](/filings/0001053706-26-000021.md) | [36.5 d](/filings/0001053706-25-000029.md) | [60.0 d](/filings/0001053706-26-000006.md) | [(114)](/filings/0001053706-26-000014.md) | [(4.4) d](/filings/0001053706-26-000021.md) |
| Capital expenditure | $m | [0.7 d](/filings/0001053706-24-000026.md) | [0.4 d](/filings/0001053706-26-000006.md) | [0.7](/filings/0001053706-25-000014.md) | [2.3 d](/filings/0001053706-25-000020.md) | [3.0 d](/filings/0001053706-25-000029.md) | [10.6 d](/filings/0001053706-26-000006.md) | [1.0](/filings/0001053706-26-000014.md) | [1.2 d](/filings/0001053706-26-000021.md) | [0.7 d](/filings/0001053706-25-000029.md) | [1.1 d](/filings/0001053706-26-000006.md) | [2.6](/filings/0001053706-26-000014.md) | [1.6 d](/filings/0001053706-26-000021.md) |
| Dividends paid | $m | [2.5 d](/filings/0001053706-24-000026.md) | [3.0 d](/filings/0001053706-26-000006.md) | [3.1](/filings/0001053706-25-000014.md) | [2.9 d](/filings/0001053706-25-000020.md) | [2.9 d](/filings/0001053706-25-000029.md) | [3.5 d](/filings/0001053706-26-000006.md) | [3.5](/filings/0001053706-26-000014.md) | [3.4 d](/filings/0001053706-26-000021.md) | [3.2 d](/filings/0001053706-25-000029.md) | [3.7 d](/filings/0001053706-26-000006.md) | [3.8](/filings/0001053706-26-000014.md) | [3.6 d](/filings/0001053706-26-000021.md) |
| Share repurchases | $m | [0.0 d](/filings/0001053706-24-000026.md) | [7.8 d](/filings/0001053706-26-000006.md) | [9.2](/filings/0001053706-25-000014.md) | [24.1 d](/filings/0001053706-25-000020.md) | [0.0 d](/filings/0001053706-25-000029.md) | [0.0 d](/filings/0001053706-26-000006.md) | [0.0](/filings/0001053706-26-000014.md) | [43.2 d](/filings/0001053706-26-000021.md) | [4.0 d](/filings/0001053706-25-000029.md) | [0.0 d](/filings/0001053706-26-000006.md) | [21.5](/filings/0001053706-26-000014.md) | [27.8 d](/filings/0001053706-26-000021.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Dividends paid: us-gaap:PaymentsOfDividends
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q3 FY2022 (2022-10-01) | Q1 FY2023 (2023-04-01) | Q2 FY2023 (2023-07-01) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-30) | Q2 FY2024 (2024-06-29) | Q3 FY2024 (2024-09-28) | Q1 FY2025 (2025-03-29) | Q2 FY2025 (2025-06-28) | Q3 FY2025 (2025-09-27) | Q1 FY2026 (2026-04-04) | Q2 FY2026 (2026-07-04) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | thousands of shares | [7,246](/filings/0001053706-23-000026.md) | [7,252](/filings/0001053706-24-000013.md) | [7,080](/filings/0001053706-24-000020.md) | [7,083](/filings/0001053706-24-000026.md) | [7,011](/filings/0001053706-25-000014.md) | [6,911](/filings/0001053706-25-000020.md) | [6,843](/filings/0001053706-25-000029.md) | [6,862](/filings/0001053706-26-000014.md) | [6,753](/filings/0001053706-26-000021.md) | [6,621](/filings/0001053706-25-000029.md) | [6,588](/filings/0001053706-26-000014.md) | [6,407](/filings/0001053706-26-000021.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 6,276,860 at 2026-07-31, from the cover of the [10-Q filed 2026-08-06](/filings/0001053706-26-000021.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:31 ET. No prices; not investment advice.